Brokers' Take
These Singapore winners can benefit from AI boom, power crunch: Morgan Stanley
A ‘glut’ of new LNG supply from the US and Qatar is set to hit Asian markets
CGSI downgrades DBS to ‘hold’ on ‘muted’ Q4 performance forecast; S$60.50 target price unchanged
FY2026 could post a larger-than-expected drop in earnings due to downside risks, says CGSI
RHB initiates ‘buy’ on Coliwoo amid rising expat, foreign student demand
The bank assigns it a target price of S$0.82, a 41% upside from its latest closing price of S$0.58 on Wednesday
Maybank initiates ‘buy’ coverage on Soon Hock with S$0.75 target
The real estate player’s profit is expected to surge, given its project pipeline
UOBKH initiates coverage on NTT DC Reit with ‘buy’, forecasts 41% upside
The analyst points out that the Reit has enjoyed a ‘steady rise’ in portfolio occupancy
Strong January lifts odds of another record year for STI, further upside ahead: OCBC
It is often a ‘good period’ for investors to reposition their portfolios
UOBKH rates top pick DBS a ‘buy’ on 5.6% yield
It also upgrades the overall banking sector to ‘overweight’ and keeps its ‘buy’ call for OCBC
‘Steepest discount’: Analysts bullish on office picks after S-Reits’ best run since 2019
Office S-Reits are undervalued, trading at the steepest discount to book value among this asset class
Supermarkets, health-and-beauty retailers set to perform in 2026, DBS says, naming top picks
Aletheia Capital downgrades ThaiBev due to Thailand’s alcohol restrictions
Revitalised IPO market, policy tailwinds could drive STI past 5,000 by end-2026: analysts
Regional stocks also up, with Japan’s Nikkei index closing at all-time high of 52,518.08 points
